Search

Author/Creator Gordon, Stuart C

1. A Phase I, Randomized, Placebo-Controlled, 3-Day, Ascending-Dose Study of Gs-9451, An Ns3/4A Protease Inhibitor, in Genotype 1 Hepatitis C Patients. Issue 3 (April 2013)

Authors:
Lawitz, Eric J; Hill, John M; Marbury, Thomas; DeMicco, Michael P; Delaney, William; Yang, Jenny; Moorehead, Lisa; Mathias, Anita; Mo, Hongmei; McHutchison, John G; Rodriguez-Torres, Maribel; Gordon, Stuart C
Journal:
Antiviral therapy
Issue:
Volume 18:Issue 3(2013)
Page Start:
311
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Deferred treatment with sofosbuvir–velpatasvir–voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1. (August 2018)

Authors:
Bourlière, Marc; Gordon, Stuart C; Schiff, Eugene R; Tran, Tram T; Ravendhran, Natarajan; Landis, Charles S; Hyland, Robert H; Stamm, Luisa M; Zhang, Jie; Dvory-Sobol, Hadas; Subramanian, G Mani; Brainard, Diana M; McHutchison, John G; Serfaty, Lawrence; Thompson, Alex J; Sepe, Thomas E; Curry, M...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 3:Number 8(2018)
Page Start:
559
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. IDDF2018-ABS-0111 Safety and efficacy of treatment with once-daily LEDIPASVIR/SOFOSBUVIR (90/400 MG) for 12 weeks in genotype 1 hcv-infected patients with severe renal impairment. (June 2018)

Authors:
Lawitz, Eric; Landis, Charles S; Maliakkal, Benedict J; Bonacini, Maurizio; Ortiz-Lasanta, Grisell; Zhang, Jie; Mogalian, Erik; De-Oertel, Shampa; Osinusi, Anu O; Brainard, Diana M; McHutchison, John G; Sze Man Yip, Christina; Huang, Hai Cheng; Flamm, Steven L; Gordon, Stuart C; Gane, Edward J
Journal:
Gut
Issue:
Volume 67(2018)Supplement 2
Page Start:
A99
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. IDDF2018-ABS-0113 The safety and tolerability of sof/vel/vox for 8 or 12 weeks in >1, 000 patients treated in the polaris-1, polaris-2, polaris-3, and polaris-4 studies: an integrated analysis. (8th June 2018)

Authors:
Manns, Michael P; Gane, Edward; Willems, Bernard E; Roberts, Stuart K; Flamm, Steven; Bourliere, Marc; Asselah, Tarik; Alric, Laurent; Hyland, Robert H; Stamm, Luisa M; Huang, KC; Brainard, Diana M; Yip, Chrstina SM; Huang, Hai Cheng; Khalili, Mandana; Foster, Graham R; Gordon, Stuart C; Reddy, K...
Journal:
Gut
Issue:
Volume 67(2018)Supplement 1
Page Start:
A302
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. IDDF2018-ABS-0114 SOF/VEL/VOX results in high SVR12 rates when administered for 12 weeks in DAA-experienced patients or for 8 weeks in daa-naive patients: an integrated analysis of the polaris-1, polaris-2, polaris-3 and polaris-4 studies. (June 2018)

Authors:
Roberts, Stuart K; Cooper, Curtis L; Lawitz, Eric; Rajender Reddy, K; Thompson, Alex J; Zeuzem, Stefan; Jacobson, Ira M; Ruane, Peter; Hyland, Robert H; Stamm, Luisa M; Han, Lingling; Brainard, Diana M; Yip, Christina SM; Huang, HC; Brau, Norbert; Asselah, Tarik; Willems, Bernard E; Flamm, Steven...
Journal:
Gut
Issue:
Volume 67(2018)Supplement 2
Page Start:
A100
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Incidence of Malignancies Among Patients With Chronic Hepatitis B in US Health Care Organizations, 2006–2018 . (17th January 2022)

Authors:
Spradling, Philip R; Xing, Jian; Zhong, Yuna; Rupp, Loralee B; Moorman, Anne C; Lu, Mei; Teshale, Eyasu H; Schmidt, Mark A; Daida, Yihe G; Boscarino, Joseph A; Gordon, Stuart C
Journal:
Journal of infectious diseases
Issue:
Volume 226:Number 5(2022)
Page Start:
896
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Long‐term progression of viral load and serum markers of fibrosis among treated and untreated patients with chronic hepatitis B. Issue 6 (30th May 2017)

Authors:
Li, Jia; Gordon, Stuart C; Rupp, Loralee B; Zhang, Talan; Trudeau, Sheri; Holmberg, Scott D; Moorman, Anne C; Spradling, Philip R; Teshale, Eyasu H; Boscarino, Joseph A; Daida, Yihe G; Schmidt, Mark A; Lu, Mei
Journal:
Journal of gastroenterology and hepatology
Issue:
Volume 32:Issue 6(2017)
Page Start:
1250
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Long‐term progression of viral load and serum markers of fibrosis among treated and untreated patients with chronic hepatitis B. Issue 6 (June 2017)

Authors:
Li, Jia; Gordon, Stuart C; Rupp, Loralee B; Zhang, Talan; Trudeau, Sheri; Holmberg, Scott D; Moorman, Anne C; Spradling, Philip R; Teshale, Eyasu H; Boscarino, Joseph A; Daida, Yihe G; Schmidt, Mark A; Lu, Mei
Journal:
Journal of gastroenterology and hepatology
Issue:
Volume 32:Issue 6(2017)
Page Start:
1250
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Lower Rates of Emergency Department Visits and Hospitalizations Among Patients With Chronic Hepatitis C With Sustained Virological Response to Interferon-Free Direct-Acting Antiviral Therapy (2014–2018) . (11th February 2022)

Authors:
Gordon, Stuart C; Teshale, Eyasu H; Spradling, Philip R; Moorman, Anne C; Boscarino, Joseph A; Schmidt, Mark A; Daida, Yihe G; Rupp, Loralee B; Trudeau, Sheri; Zhang, Jiaqi; Lu, Mei
Journal:
Clinical infectious diseases
Issue:
Volume 75:Number 8(2022)
Page Start:
1453
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗